ArticleNature communications2025

Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC/CDK2/DNMT1 pathway.

Wan-Cheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.